advisorsecurities master

TILInstil Bio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
22519
Ticker
TIL
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-03-19
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
TIL

Detail

Enriched 2026-08-14 20:47

Market cap
$50,729,180.48
Shares outstanding (class)
6,781,976
Shares outstanding (weighted)
6,781,976
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
17
Location
DALLAS, TX
Description

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data